Silvaco Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 4, 2026, disclosing a net loss of $4,586 thousand for the third quarter and $14,123 thousand for the nine months ended September 30, 2026.

Key Highlights

  • Q3 2026 total revenue: $16,294 thousand, compared to $18,672 thousand in Q3 2025, according to the filing.
  • Nine-month total revenue: $51,855 thousand for the nine months ended September 30, 2026, up from $44,812 thousand in the same period of 2025.
  • Q3 2026 net loss: $4,586 thousand, or $(0.14) per basic and diluted share, versus a net loss of $5,299 thousand, or $(0.18) per share, in Q3 2025.
  • Cash and cash equivalents: $22,014 thousand as of September 30, 2026, up from $9,008 thousand at December 31, 2025.
  • Shares outstanding: 34,073,072 shares of common stock as of September 30, 2026, compared to 30,948,403 at December 31, 2025.
  • Convertible note payable: $10,108 thousand recorded as a non-current liability as of September 30, 2026, with no comparable balance at December 31, 2025.
  • Accumulated deficit: $(83,341) thousand as of September 30, 2026, compared to $(69,218) thousand at December 31, 2025.

Silvaco Group Q3 2026 Financial Results: Revenue, Losses, and Balance Sheet Changes

Silvaco Group, Inc. (NASDAQ:SVCO), a Santa Clara, California-based company, reported its condensed consolidated financial results for the three and nine months ended September 30, 2026. According to the filing, total revenue for Q3 2026 was $16,294 thousand, comprised of $10,859 thousand in software license revenue and $5,435 thousand in maintenance and service revenue. This compares to Q3 2025 total revenue of $18,672 thousand, which included $13,757 thousand in software license revenue and $4,915 thousand in maintenance and service revenue. Gross profit for Q3 2026 was reported as $13,686 thousand, with cost of revenue at $2,608 thousand.

For the nine months ended September 30, 2026, the company reported total revenue of $51,855 thousand versus $44,812 thousand in the comparable prior-year period. The filing disclosed a nine-month operating loss of $(13,947) thousand, narrowing from $(39,117) thousand in the nine months ended September 30, 2025, which included a $13,069 thousand litigation settlement charge. General and administrative expenses for the nine months were $20,242 thousand in 2026, compared to $27,062 thousand in 2025. Research and development expenses were $25,161 thousand for the nine months ended September 30, 2026, against $19,446 thousand for the same period in 2025.

On the balance sheet, total assets were $121,884 thousand as of September 30, 2026, compared to $122,642 thousand at December 31, 2025. The company disclosed a new convertible note payable of $10,108 thousand in non-current liabilities. Total stockholders' equity increased to $81,921 thousand from $74,989 thousand at year-end 2025, reflecting, in part, $11,051 thousand in proceeds from common stock issuances under an open market sale agreement, net of commissions and related fees, and $1,232 thousand from stock issued to settle obligations related to a Tech-X shareholder. As of November 2, 2026, the registrant reported 34,196,912 shares of common stock outstanding.

What Was Disclosed

Silvaco Group filed its quarterly report covering the period ended September 30, 2026, disclosing revenue, net loss, balance sheet data, and equity activity for Q3 2026 and the nine months year-to-date, including a new convertible note payable and increased share count from equity issuances.